Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Celularity (CELU) Shares Issued (2020 - 2025)

Celularity (CELU) has disclosed Shares Issued for 6 consecutive years, with -$902000.0 as the latest value for Q3 2025.

  • For Q3 2025, Shares Issued changed N/A year-over-year to -$902000.0; the TTM value through Dec 2025 reached $108000.0, up 86.21%, while the annual FY2025 figure was $108000.0, 86.21% up from the prior year.
  • Shares Issued hit -$902000.0 in Q3 2025 for Celularity, up from -$1.4 million in the prior quarter.
  • Across five years, Shares Issued topped out at $83.2 million in Q4 2021 and bottomed at -$5.9 million in Q4 2024.
  • Average Shares Issued over 5 years is $6.9 million, with a median of $226500.0 recorded in 2022.
  • Year-over-year, Shares Issued surged 96617.44% in 2021 and then tumbled 99.74% in 2022.
  • Celularity's Shares Issued stood at $83.2 million in 2021, then crashed by 99.74% to $215000.0 in 2022, then soared by 5688.84% to $12.4 million in 2023, then crashed by 147.74% to -$5.9 million in 2024, then skyrocketed by 84.82% to -$902000.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at -$902000.0, -$1.4 million, and $2.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.